Edition:
United States

Entest Biomedical Inc (ENTB.PK)

ENTB.PK on OTC Markets Group

0.04USD
21 Aug 2017
Change (% chg)

$-0.00 (-0.26%)
Prev Close
$0.04
Open
$0.03
Day's High
$0.04
Day's Low
$0.03
Volume
1,100
Avg. Vol
81,624
52-wk High
$0.09
52-wk Low
$0.00

ENTB.PK

Chart for ENTB.PK

About

Entest BioMedical, Inc. is engaged in the development and commercialization of immunotherapeutic therapies for the veterinary market, as well as the acquisition and operation of veterinary hospitals. The Company is engaged in the development and commercialization of ImenVax, a therapeutic cancer vaccine for use in canines, and... (more)
No analyst recommendations are available for ENTB.PK.

Overall

Beta: -3.28
Market Cap(Mil.): $1.70
Shares Outstanding(Mil.): 44.22
Dividend: --
Yield (%): --

Financials

  ENTB.PK Industry Sector
P/E (TTM): -- 29.35 32.56
EPS (TTM): -0.01 -- --
ROI: -- 6.60 14.89
ROE: -- 10.47 16.13

Earnings vs. Estimates

No consensus analysis data available.